These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 8490983)

  • 21. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment.
    Butterworth AE; Dalton PR; Dunne DW; Mugambi M; Ouma JH; Richardson BA; Siongok TK; Sturrock RF
    Trans R Soc Trop Med Hyg; 1984; 78(1):108-23. PubMed ID: 6710563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment.
    Sturrock RF; Bensted-Smith R; Butterworth AE; Dalton PR; Kariuki HC; Koech D; Mugambi M; Ouma JH; arap Siongok TK
    Trans R Soc Trop Med Hyg; 1987; 81(2):303-14. PubMed ID: 3113005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helminth and snail survey in Harerge region of Ethiopia with special reference to schistosomiasis.
    Lo CT; Ayele T; Birrie H
    Ethiop Med J; 1989 Apr; 27(2):73-83. PubMed ID: 2496975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.
    Utzinger J; N'Goran EK; N'Dri A; Lengeler C; Xiao S; Tanner M
    Lancet; 2000 Apr; 355(9212):1320-5. PubMed ID: 10776745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosomiasis mansoni in Bananal (State of São Paulo, Brazil): I. Efficiency of diagnostic and treatment procedures.
    Teles HM; de Carvalho ME; Santos Ferreira C; Zacharias F; de Lima VR; Fadel ML
    Mem Inst Oswaldo Cruz; 2002; 97 Suppl 1():181-6. PubMed ID: 12426617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional and evolutive studies of schistosomiasis mansoni in untreated and mass treated endemic areas in the southeast and northeast of Brazil.
    Coura JR; Conceição J; dos Santos ML; de Mendonça ZG; Cutrim RN
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():175-82. PubMed ID: 1343891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A three year follow-up of chemotherapy with oxamniquine in a Brazilian community with endemic schistosomiasis mansoni.
    Sleigh AC; Mott KE; Silva JT; Muniz TM; Mota EA; Barreto ML; Hoff R; Maguire JH; Lehman JS; Sherlock I
    Trans R Soc Trop Med Hyg; 1981; 75(2):234-8. PubMed ID: 7303137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Cytokine and Chemokine Profiles in Individuals With
    Castro VN; Rodrigues JL; Cardoso DT; Resende SD; Magalhães FC; Souza DC; Requeijo MH; Negrão-Corrêa D; Geiger SM
    Front Immunol; 2018; 9():2975. PubMed ID: 30619332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schistosomiasis mansoni in an area of low transmission. I. Impact of control measures.
    Marçal Júnior O; Patucci RM; Dias LC; Hotta LK; Etzel A
    Rev Inst Med Trop Sao Paulo; 1991; 33(2):83-90. PubMed ID: 1844388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal.
    De Clercq D; Vercruysse J; Picquet M; Shaw DJ; Diop M; Ly A; Gryseels B
    Trop Med Int Health; 1999 Aug; 4(8):544-50. PubMed ID: 10499077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of schistosomiasis mansoni in indigenous Maxakali villages, Minas Gerais, Brazil.
    Nacife MBPESL; Siqueira LMV; Martins R; Vianna VN; Barbosa KF; Masioli CZ; Silva JCD; Machado-Coelho GLL
    Rev Inst Med Trop Sao Paulo; 2018; 60():e26. PubMed ID: 29972467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
    Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
    Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors involved in Schistosoma mansoni infection in rural areas of northeast Brazil.
    Coutinho EM; Abath FG; Barbosa CS; Domingues AL; Melo MC; Montenegro SM; Lucena MA; Romani SA; Souza WV; Coutinho AD
    Mem Inst Oswaldo Cruz; 1997; 92(5):707-15. PubMed ID: 9566243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schistosoma mansoni along Lake Albert, Kibale District, Western Uganda.
    Kabatereine NB; Odongo-Aginya EI; Lakwo TL
    East Afr Med J; 1996 Aug; 73(8):502-4. PubMed ID: 8964244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new focus of schistosomiasis mansoni in Hayk town, northeastern Ethiopia.
    Amsalu G; Mekonnen Z; Erko B
    BMC Res Notes; 2015 Feb; 8():22. PubMed ID: 25643852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific schistosomiasis treatment as a strategy for disease control.
    Coura JR; Conceição MJ
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):598-603. PubMed ID: 20721513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parasitological, Pathological, and Immunological Parameters Associated with Schistosoma mansoni Infection and Reinfection in BALB/c AND C57BL/6 Mice.
    Alves CC; Araujo N; Cassali GD; Fonseca CT
    J Parasitol; 2016 Jun; 102(3):336-41. PubMed ID: 26928866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study.
    Karanja DM; Hightower AW; Colley DG; Mwinzi PN; Galil K; Andove J; Secor WE
    Lancet; 2002 Aug; 360(9333):592-6. PubMed ID: 12241930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.